Venous Air Embolism During Supine Craniotomy For Aneurysm: Role of Hyperbaric Oxygen Therapy
J Nates, J Aristizabal, D Kim, C Fife
anesthesia, anesthesiology, critical care medicine, education, electronic publication, intensive care medicine, internet, multimedia, online, peer-review, regional anesthesia, trauma
J Nates, J Aristizabal, D Kim, C Fife. Venous Air Embolism During Supine Craniotomy For Aneurysm: Role of Hyperbaric Oxygen Therapy. The Internet Journal of Emergency and Intensive Care Medicine. 1999 Volume 4 Number 2.
Venous air embolism (VAE) has been estimated to occur in 45% and 12% of the patients undergoing craniotomies in sitting and supine position respectively 1. The number of cases reported has dropped dramatically in last few years, probably due to the fact that it is a well recognized complication and has been already described in the literature during anesthesia in sitting position, cesarean section, laparoscopy, and many others 2345678. However, it is less known that despite the differences in the incidence of minor VAE episodes during sitting position procedures, the incidence of major cardio-repiratory events as result of VAE is the same (1.5%) in patients undergoing a craniotomy in either position 1. Recently, many authors have noted the lack of awareness of physicians to recognize VAE 567. This and the fact that hyperbaric oxygen (HBO2) therapy is not readily available in many institutions or even considered, reduce the likelihood that patients will receive rapid treatment after air embolism.
We report a case of a clinically diagnosed VAE and suspected paradoxical embolism (PAE) that responded to rapid HBO2 therapy. Our main purpose is to increase awareness among anesthesiologists of the use of HBO2 in arterial air embolism regardless of etiology, particularly since this well recognized complication still remains under treated in most cases.
A seventy-eight year-old Hispanic female was admitted to our institution complaining of severe headache and saying, “she was going to die”. She had previous history of coronary heart disease, chronic obstructive pulmonary disease, hypercholesterolemia, chronic gastritis, new onset arterial hypertension and diverticulosis. She had a previous cholecystectomy, left inguinal herniorraphy and right carpal tunnel surgery with no history of allergies or alcohol/tobacco use. Her medications included cimetidine and pravastatine. On arrival to the emergency room she was confused with a Glasgow Coma Score (GCS) 13 (E-3, V-4, M-6), no focal motor deficits or cranial nerve abnormalities were evident, and both pupils were equal and reactive to light and accommodation. A CT scan of her brain showed subarachnoid hemorrhage. A four-vessel cerebral digital subtraction angiography showed a right middle cerebral artery aneurysm and the patient was taken to the operating room for urgent craniotomy.
A central venous line in the right internal jugular vein and an arterial line in the right radial artery were inserted before the procedure started under general endotracheal anesthesia (GETA) in supine position. No precordial Doppler was used but, pulse oximeter, capnograph, EKG, temperature, and a six-channel electroencephalogram (EEG) and bilateral ulnar nerve somatosensory evoked potentials (SEP) were monitored from the beginning of the operation. Twenty five minutes after the scalp had been reflected anteriorly and a burr hole in the right frontal bone had been made, the patient had a sudden drop in end tidal CO2 from 34 to 24 mmHg, followed by a drop in the systolic blood pressure from 140 to 40 mmHg. The anesthesiologists discontinued the nitrous oxide and began resuscitation with 100% FiO2, intravenous fluids, and 3 consecutive doses of adrenaline intravenously (1mg, 0.5 mg and 0.75 mg) while the EEG and SEP flattened and the blood pressure remained low for more than 6 minutes. A right frontal ventriculostomy was placed immediately to rule out rebleeding, the intracranial pressure measured <25 mmHg and the surgeon ruled out this possibility. At 11 minutes into the event, the EEG began to gain amplitude and SEP activity returned but with delayed latency. An embolic event was suspected but due to the risks of rupture of the aneurysm, it was decided to finish the clipping to protect the patient from a catastrophic hemorrhage and hyperbaric therapy was delayed to the end of the procedure. The surgery continued when blood pressure control was achieved, and an eight-mm right middle cerebral artery aneurysm was found and clipped through an extensive anterior skull-base approach. Two hours after the period of hypotension, the patient was transferred to the neurological intensive care unit (NCCU) for further management. The patient had remained stable hemodynamically but the SEP was still delayed and the amplitude of the EEG was still below basal readings under anesthesia.
On arrival to the NCCU, the patient was hemodynamically stable, on no vasopressors, CVP was 9 mmHg, her GCS was 7-T (E=1, V=T, M=5), and the pupils were equal and responsive to light. There was also a major drop in the PaO2/FiO2 ratio (P/F ratio = 155) without chest X-ray correlating pathology (see picture 1), increased base deficit, hypovolemia or hypotension. With the clinical diagnosis of venous air embolism and possible arterial gas embolism, the Hyperbaric Medicine team was consulted for urgent HBO2 therapy. The hyperbaric team concurred with the diagnosis and the patient received a hundred percent oxygen in a US Navy table 6 in a large multiplace hyperbaric chamber, which allowed critical care personnel to be in attendance of a ventilated critically ill patient like this. The patient was readmitted to the ICU after the hyperbaric oxygen treatment without complications, obeying commands and moving all extremities with no apparent neurological sequelae (GCS 11-T, E=4, V=T, M=6) except for confusion evident after extubation (GCS 14, E=4, V=4, M=6). The P/F ratio had returned to normal (>500), and the awake patient was extubated successfully. Next morning, the post-op EKG was unchanged and serial cardiac enzymes were within the normal limits; a bubble contrast echocardiogram confirmed a patent foramen ovale. The patient was followed daily with daily transcranial Doppler (TCD) but she did not develop cerebral vasospasm and was transferred to the ward with a GCS 15 a few days later. During her stay in the hospital there were no further complications, and the patient was discharged home with no neurological deficits.
VAE has been treated with changes in position, fluids, vasopressors, G-suits, neck venous compression, and increased positive end expiratory pressure (PEEP), among others 8. However HBO2, a less available or recognized therapy, is the treatment of choice for air embolism of any origin 9. Its early use is definitely indicated for this disorder because supportive or pharmacological therapy alone will not decrease or resolve damage to the organs caused by the air emboli. HBO2 benefits patients with air embolism by reducing the volume of the gas bubbles (Boyle’s Law), relieving obstruction to blood flow, increasing oxygen delivery to the tissues and reducing the morbidity and mortality from inflammatory reaction and failure of the affected organs. In addition, it favors nitrogen diffusion (Henry’s Law) from the bubbles with complete removal of the gas from the bubbles further reducing their size. Bert 10 suggested HBO2 in the treatment of this complication for the first time in 1878.
In 1985, Murphy et al. 11 reported 16 cases treated with HBO2 over a period of 14 years. In 1987, Takahashi et al. 12 reported 34 cases where HBO2 was administered as the first choice. In their series there were 4 craniotomies in the sitting position; all patients suffered hypotension, 3 had altered mental status (coma), and 1 cardiac arrest. The patients were treated within 2 to 5 hours; however only 2 had good outcome. In 1990, Massey et al. 13 reported 14 patients with iatrogenic air embolism treated with HBO2. No statistical difference in outcome was found between the groups treated early and late (after 24 hours). Since even some patients with greater than a 24 hours delay to treatment appeared to respond to HBO2, the authors recommend HBO2 even in the event of unavoidable treatment delay. In 1992, Pelaia et al. 14 reported 14 patients with arterial air embolism (AAE) during cardiopulmonary by-pass treated with U.S. Navy table 6A modified. The authors divided the patients in 2 groups, group A= < 5 hours to HBO2 and group B= 24-48 hours to treatment. At 12 hours after the witnessed embolism episodes, the CT scans of the brain in 10 patients were normal, only 3 patients had severe brain edema. In 4 of the patients of group A, the CT scan of the brain showed focal areas of hypodensity without cerebral edema at 72 hours. The incidence of neurological symptoms in the group A was 40% versus 100% in the delayed therapy group. Interestingly at 3 months, the neurological recovery was complete in all group A patients; in contrast, all the patients in group B died within 20 days. The above series support the need for early HBO2 therapy; however, delay even after 24 hours of therapy may still be beneficial 1315. Dexter and Hindman 16 when trying to answer the question of what volume of air is enough to trigger a hyperbaric treatment in patients with cerebral arterial air embolism during cardiopulmonary bypass found that, if the air bubbles are large enough to be seen on CT scan of the brain, the air will not be absorbed for hours or days. They concluded that this population would benefit from delayed hyperbaric treatment.
Based on the above, we hypothesize that in our patient, early therapy prevented the neurological consequences of the VAE or PAE and corrected the ventilation/perfusion defect secondary to an increase in the dead space from the air in the pulmonary tree. The U.S. Navy table 6 (see figure 1) was used immediately after surgery was completed (2 hours from event)17. The maximum pressure was 2.8 atmospheres absolute (ATA); for 60 minutes with the patient breathing 100% FiO2. After an ascent rate of 1 foot per minute, the patient was treated at 1.9 ATA for another 120 minutes. The total time of this treatment was 285 minutes not including descent time (see fig. 1).
Despite great concern of a PAE with irreversible neurological injury, at the end of the compression and hyperbaric treatment, the patient was neurologically intact and awake. Furthermore, the ventilation/perfusion abnormality seen before the compression to 2.8 ATA was completely resolved allowing immediate extubation.
The incidence of air embolism in patients undergoing cardiac surgery varies between 79% using transesophageal echocardiography 18 to 100% using transcranial Doppler 19 in open heart surgery; and as we mentioned previously, in 45% of the patients undergoing craniotomies in sitting position. Neurological deficits from small amounts of arterialized gas are rare, and we would not recommend HBO2 for all patients in whom evidence of arterial bubbles is obtained with Doppler. However, for the 0.1% of patients who develop clinically significant arterial gas embolism during cardiopulmonary bypass 20 and the 1.5% who experience this complication during craniotomy 1, HBO2 should be available as quickly as possible.
Anesthesiologists are exposed to more VAE cases than any other health professional. Every day, anesthesiologists provide anesthesia for laparoscopy, neck dissection, neurosurgery, intravascular procedures, obstetrics, and others, including insertion of central venous lines. As anesthesiologists, the likelihood of being involved in such a case is high, and to know the role of HBO2 in VAE, PAE or AAE as well as to have an institutional algorithm for emergencies is critical.
IMPORTANT NOTICE IN CASE OF EMERGENCY
A listing of HBO2 chambers around the country is available from the